The division is focused on identifying both the genetic and environmental causes of breast cancer, so we can improve diagnosis, assess prognosis and likely response to treatment more accurately, and ...

The Centre for In Vivo Modelling is a newly established research centre within the Division of Cancer Biology at the ICR. Our scientists and clinical researchers use state-of-the-art in vivo models to ...

Scientists have identified the genetic blueprints of 18 previously unknown bacterial species in DNA samples from people with prostate cancer. The study, led by researchers at the University of East ...

Nearly one third (29.2 per cent) of patients with advanced melanoma saw their tumours disappear completely on scans after receiving lifileucel TIL therapy alongside an immune checkpoint inhibitor, ...

Join us We are recruiting two exceptional Group Leaders to join the Division of Cancer Biology and the Centre for In Vivo Modelling (CIVM). This is a unique opportunity to shape the future of cancer ...

The Audit & Risk Committee supervises internal and external audit processes in order to safeguard the integrity of the ICR's financial systems and ensure economy, efficiency and effectiveness in the ...

Bladder cancers have variable infiltration of cancer-associated fibroblasts (CAFs). Bladder tumours with more CAFs are associated with worse outcomes after chemotherapy, surgery, immunotherapy and ...

Metastasis, but not the primary tumour, is what leads to the majority of cancer-related deaths, with the liver representing one of the most frequent sites of metastasis for solid tumours 1. Among ...

Soft tissue sarcomas (STS) are a rare and heterogeneous group of malignancies arising from connective tissues such as muscle, fat and nerve sheaths. Comprising more than 100 histological subtypes, STS ...

Paediatric-type diffuse high-grade gliomas (PDHGG) are aggressive childhood brain tumours with devastating prognosis(1). Immunotherapy for these patients is gathering momentum(2). Oncolytic virus (OV) ...